![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 19, 16828-16833, May 9, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
From the Department of Integrated Biosciences, Graduate School of
Frontier Sciences, University of Tokyo, 5-1-5 Kashiwanoha,
Kashiwa, Chiba Prefecture 277-8562, Japan
Pathogenic point mutations in mitochondrial tRNA
genes are known to cause a variety of human mitochondrial diseases.
Reports have associated an A4317G mutation in the mitochondrial
tRNAIle gene with fatal infantile cardiomyopathy and
an A10044G mutation in the mitochondrial tRNAGly gene with
sudden infant death syndrome. Here we demonstrate that both mutations
inhibit in vitro CCA-addition to the respective tRNA by the
human mitochondrial CCA-adding enzyme. Structures of these two mutant
tRNAs were examined by nuclease probing. In the case of the A4317G
tRNAIle mutant, structural rearrangement of the T-arm
region, conferring an aberrantly stable T-arm structure and an
increased Tm value, was clearly observed. In the
case of the A10044G tRNAGly mutant, high nuclease
sensitivity in both the T- and D-loops suggested a weakened interaction
between the loops. These are the first reported instances of
inefficient CCA-addition being one of the apparent molecular
pathogeneses caused by pathogenic point mutations in human
mitochondrial tRNA genes.
These authors contributed equally to this work.
§
To whom correspondence should be addressed: Dept. of Integrated
Biosciences, Graduate School of Frontier Sciences, University of Tokyo,
Bldg. FSB-301, 5-1-5 Kashiwanoha, Kashiwa, Chiba Prefecture, 277-8562, Japan. Tel.: 81-4-7136-5401; Fax: 81-4-7136-3602; E-mail: t-suzuki@k.u-tokyo.ac.jp.
This article has been cited by other articles:
![]() |
L. Bonnefond, C. Florentz, R. Giege, and J. Rudinger-Thirion Decreased aminoacylation in pathology-related mutants of mitochondrial tRNATyr is associated with structural perturbations in tRNA architecture RNA, April 1, 2008; 14(4): 641 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ling, H. Roy, D. Qin, M. A. T. Rubio, J. D. Alfonzo, K. Fredrick, and M. Ibba Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome PNAS, September 25, 2007; 104(39): 15299 - 15304. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Levinger, M. Morl, and C. Florentz Mitochondrial tRNA 3' end metabolism and human disease Nucleic Acids Res., October 11, 2004; 32(18): 5430 - 5441. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hino, T. Suzuki, T. Yasukawa, K. Seio, K. Watanabe, and T. Ueda The pathogenic A4269G mutation in human mitochondrial tRNAIle alters the T-stem structure and decreases the binding affinity for elongation factor Tu Genes Cells, March 1, 2004; 9(3): 243 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Temperley, S. H. Seneca, K. Tonska, E. Bartnik, L. A. Bindoff, R. N. Lightowlers, and Z. M.A. Chrzanowska-Lightowlers Investigation of a pathogenic mtDNA microdeletion reveals a translation-dependent deadenylation decay pathway in human mitochondria Hum. Mol. Genet., September 15, 2003; 12(18): 2341 - 2348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |